文献速递关节外科骨质疏松与代谢性骨病

新型冠状病毒相关骨坏死的危险因素、发病机制、诊断与治疗选择:一项系统综述

Risk Factors, Pathogenesis, Diagnosis, and Treatment Options for COVID-Associated Osteonecrosis: A Systematic Review.
PubMed 文献 · J Arthroplasty · 2025-06-07

该系统综述共纳入10篇文章,旨在明确新型冠状病毒相关骨坏死的临床表现与流行病学、病理生理、诊断方式及治疗指南或流程。结果显示从感染到出现骨坏死症状的间隔时间差异较大,临床表现与标准骨坏死症状相似,皮质类固醇倾向为最可识别的相关危险因素,诊断依靠X线片和磁共振成像,治疗依骨坏死进展速度从双膦酸盐和镇痛药到保关节手术和全关节置换不等。

要点

  • 皮质类固醇倾向为新型冠状病毒相关骨坏死最可识别的相关危险因素。
  • 诊断包括X线片和磁共振成像以明确诊断。
  • 治疗依骨坏死进展速度而异,从双膦酸盐和镇痛药到保关节手术和全关节置换。

核心结论

  • 新型冠状病毒相关骨坏死虽属相对罕见的临床疾病,但骨科医生应有所认识并在患者中细致筛查。
  • 对感染新型冠状病毒的患者,医生应利用其临床表现、病理生理、诊断和治疗信息进行适当筛查和管理。

研究设计与样本

  • 采用系统综述和荟萃分析优先报告条目(PRISMA)指南,在三个数据库中进行系统综述,共纳入10篇文章。
  • 纳入标准为文章提供新型冠状病毒骨坏死的临床表现或流行病学、病理生理、诊断方式、治疗指南或流程中至少一方面的数据。

主要发现

  • 新型冠状病毒感染与骨坏死症状之间的间隔时间存在相当大的变异性。
  • 新型冠状病毒相关骨坏死的临床表现与标准症状相似,包括关节疼痛和负重时疼痛。
  • 皮质类固醇倾向为新型冠状病毒相关骨坏死最可识别的相关危险因素。
  • 诊断包括X线片和磁共振成像以明确诊断。
  • 治疗依骨坏死进展速度而异,范围从双膦酸盐和镇痛药到保关节手术和全关节置换。

临床怎么用

  • 骨科医生应认识新型冠状病毒相关骨坏死并在患者中细致筛查。
  • 对感染新型冠状病毒的患者,医生应利用临床表现、病理生理、诊断和治疗信息进行适当筛查和管理。

局限性

  • 从新型冠状病毒感染到骨坏死症状的间隔时间存在相当大的变异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteonecrosis associated with COVID-19 is a relatively rare clinical entity, but with a high incidence during the pandemic. There is a paucity of data regarding the characterization of this group of osteonecrosis patients. The purpose of this investigation was to systematically review the literature to identify: (1) clinical presentation/epidemiology, (2) pathophysiology, (3) diagnostic modalities, and (4) treatment guidelines/algorithms of COVID-19 osteonecrosis. METHODS: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a systematic review across three databases, resulting in a total of 10 articles. Articles met the inclusion criteria if they provided data regarding: (1) clinical presentation/epidemiology, (2) pathophysiology, (3) diagnostic modalities, and/or (4) treatment guidelines/algorithms of COVID-19 osteonecrosis. RESULTS: There was considerable variability in duration between COVID-19 infection and osteonecrosis symptoms. The clinical presentation of COVID-associated osteonecrosis is similar to standard symptoms, including joint pain and pain with weight-bearing. Corticosteroids tended to be the most identifiable associated risk factor for COVID-associated osteonecrosis. Diagnosis included radiographs and magnetic resonance imaging for definitive diagnosis. Treatment varied depending on the rapidity of osteonecrosis progression, ranging from bisphosphonates and analgesics to joint-preserving procedures and total joint arthroplasty. CONCLUSIONS: Although COVID-associated osteonecrosis is a rare clinical condition, it is one that orthopaedic surgeons should be aware of and meticulously screen for in their patients. For patients inoculated with the COVID-19 virus, it is important for surgeons to use information regarding clinical presentation, pathophysiology, diagnosis, and treatment of COVID-associated osteonecrosis to screen and manage patients appropriately.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Sequeira SB, Jones LP, Goodman SB, et al. Risk Factors, Pathogenesis, Diagnosis, and Treatment Options for COVID-Associated Osteonecrosis: A Systematic Review. J Arthroplasty. 2025. PMID: 40490144. doi:10.1016/j.arth.2025.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。